Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum SOL Global Investments Corp C.SOL

Alternate Symbol(s):  SOLCF

SOL Global Investments Corp. is a Canada-based diversified international investment and private equity holding company, which is engaged in investing in small and mid-cap sectors. SOL Global provides growth capital to small and mid-sized businesses. The Company’s investments range from minority positions to strategic holdings with active advisory mandates with an objective of providing... see more

CSE:SOL - Post Discussion

SOL Global Investments Corp > Hidden Secrete of Mushrooms
View:
Post by pahdg0208 on Feb 22, 2021 1:07pm

Hidden Secrete of Mushrooms

Sponsored Post
There are many kinds of mushroom in the world, but psilocybin mushroom is not significant to other mushroom in the field of medication. Want to learn more about this topic?
 
Expert said mushroom also describes a variety of other gilled fungi, with or without stems, therefore the term is used to describe the fleshy fruiting bodies of some Ascomycota. These gills produce microscopic spores that help the fungus spread across the ground or its occupant surface.

 Research result that, psilocybin mushrooms for the treatment of obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, eating disorders, depression and anxiety, it’s only a matter of time before companies begin to incorporate psychedelics into their own drug pipelines. Check Disclaimer on profile and landing page
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities